Among eight cephalosporins and cephamycins tested in preliminary in vitro screening against Mycobacterium tuberculosis, the most promising for further study was found to be ceforanide, followed by ceftizoxime, cephapirin, and cefotaxime. Moxalactam, cefoxitin, cefamandole, and cephalothin were found to be not active enough against M. tuberculosis to be considered for further in vitro studies. The antibacterial activity of various ceforanide concentrations was investigated by three methods: (i) the dynamics of radiometric readings (growth index) in 7H12 broth; (ii) the number of CFU in the same medium; and (iii) the proportion method on 7H11 agar plates. There was a good correlation among the results obtained with these three methods. The MIC for most strains ranged from 6.0 to 25.0 ,ug/ml. The BACTEC radiometric method is a reliable, rapid, and convenient method for preliminary screening and determination of the level of antibacterial activity of drugs not commonly used against M. tuberculosis.
The first attempts to study the activity of P-lactamaseresistant penicillins against Mycobacterium tuberculosis were made after it was ascertained that the resistance of M. tuberculosis to penicillin G was related to 1-lactamase activity (1, 2) . In a study by Lorian and Sabath (3), cloxacillin had a bactericidal effect in a concentration of 10 ,ug/ml on five of six tested strains. Misiek et al. (6) screened more than 600 semisynthetic cephalosporins against the H37Rv strain by defining the MIC by broth dilution methods (presumably by turbidity measurement) and concluded that potential antituberculosis cephalosporins should have pyridyl or aminomethylphenyl moieties in a side chain at the C-7 position. By using this approach, Sanders et al. (9) compared two cephalosporins having one or the other of these characteristics (cephapirin and ceforanide) with five having neither (cephalothin, cephalexin, cephaloglycin, cefazolin, and cephaloridine). Ceforanide and cephapirin, followed by cephalothin, were found to be the most active. Further progress in this field requires the screening of many drugs against a large number of clinical isolates which have different patterns of susceptibility to the standard antituberculosis drugs. One of the difficulties in such screening is that it is extremely labor intensive to plate the growing broth cultures at many time points to determine antibacterial effect. On the other hand, determining growth inhibition of M. tuberculosis only by measuring changes in the turbidity would not be reliable or sufficiently sensitive. The recent development of the radiometric method to detect mycobacterial growth has provided new opportunities for the in vitro screening of many drugs (including nonstable drugs). The radiometric method, by using advanced technology especially developed for mycobacteriology (BACTEC system 460-TB), has proven to be an effective tool in drug susceptibility testing (5, 7, 10, 11) .
The main aim of this study was to determine whether this radiometric method is a reliable technique for rapid screen-* Corresponding author.
ing of different antimicrobial agents and to determine the level of their activity against the clinical isolates of M. tuberculosis.
MATERIALS AND METHODS
Antimicrobial agents. The cephalosporins and cephamycins for this study were supplied by different manufacturers. Cephalothin sodium for injections (Keflin), cefamandole (Mandol), and moxalactam (Moxam) were obtained from Eli Lilly & Co., Indianapolis, Ind. Cefoxitin sodium (Mefoxin) was obtained from Merck Sharp & Dohme, West Point, Pa. Ceftizoxime sodium (Cefizox) is manufactured by Fujisawa SmithKline Corp., Osaka, Japan, and distributed by Smith Kline & French Laboratories, Philadelphia, Pa. Cefotaxime sodium (Claforan) was obtained from Hoechst-Roussel Pharmaceuticals, Inc., Somerville, N.J. Cephapirin (Cefadyl) and ceforanide (Precef) were supplied by Bristol Laboratories, Syracuse, N.Y. The drugs were reconstituted as specified by the manufacturers and then diluted to a concentration of 2,000 ,ug/ml in diluting fluid (DF), which consists of a 0.2% solution of bovine albumin fraction V (Sigma Chemical Co., St. Louis, Mo.) in 0.02% Tween 80. Drug solutions were distributed in small aliquots, kept frozen at -70°C, and used for preliminary screening. The addition of 0.1 ml of the solution to 2.0 ml of 7H12 broth in a vial produced a final concentration of 100 ,ug/ml in the medium. Twofold dilutions of the 2,000-,ug/ml solution were made in DF and kept as frozen aliquots for use in MIC titrations. The addition of 0.1 ml of such dilutions to 2.0 ml of 7H12 broth gave final concentrations ranging from 50.0 to 0.4 ,ug/ml.
Radiometric method to detect growth. The BACTEC 460-TB instrument (Johnston Laboratories, Towson, Md.) was used to detect the growth of M. tuberculosis in 7H12 broth medium (5) , which contains 14C-labeled substrates (fatty acids) as a single source of carbon. Growth leads to the consumption of this substrate with subsequent release of ANTIMICROB. AGENTS CHEMOTHER.
vial. The BACTEC instrument detects the amount of '4CO2 and records it as growth index (GI) on a scale of 0 to 999. In the present study, the GI was recorded daily to produce a picture of the dynamics of growth.
Preliminary susceptibility screening. Nine vials of 7H12 medium were inoculated with each culture. A 0.1-ml portion of 7H9 broth culture was used as an inoculum after being adjusted to the optical density of the no. 1 McFarland Standard. This inoculum produced an initial concentration of 5 x 103 to 2 x 104 CFU/ml, as determined by plating.
When the GI reached 20 to 50, 0.1-ml portions of the drug solutions (2,000 ,ug/ml) were added to eight vials to give a final concentration of 100.0 p.g/ml for each drug. The ninth vial was a control without drugs. The daily reading by means of the BACTEC instrument continued until a few days after the maximum GI in the control vial was reached. The inhibition, expressed as a ratio of the GI in vials with drugs and in control vials when the GI in the control had reached the maximum, was calculated with the following equation: inhibition = [1 -(GI in drug vial/GI in control vial)] x 100. R-MIC titration. Ten vials of 7H12 medium were inoculated with each culture under the same conditions as described above. Eight of these vials were used for testing different concentrations of the test drug. Ceforanide was the only drug selected for this study. The appropriate drug solutions (0.1 ml each) were added to the vials once, on day 1 of cultivation. Two vials were used as controls; one was inoculated in the same way as the eight vials with ceforanide and the second was inoculated with a 1:100 dilution of the inoculum to represent 1% of the bacterial population when compared with the other vials. The lowest concentration of ceforanide that completely inhibited the increase in GI, while a daily increase in GI occurred in both controls, was considered the radiometric MIC (R-MIC).
MIC determination in 7H12 broth by plating. Six experiments with different cultures were performed to compare radiometric readings (GI) with the results of plating from the same 7H12 broth cultures (CFU). For this purpose, only two concentrations of ceforanide were selected: one considered the R-MIC in a preliminary experiment with the same culture and the other a concentration which had produced a partial inhibition. Each concentration and control was inoculated in duplicate. Samples for plating were taken at different GI levels in the course of cultivation. An allergist syringe with a fixed, 27-gauge, 0.5-in (1.27-cm) needle (Becton Dickinson and Co., Paramus, N.J.) was used to draw up 0.7 to 0.8 ml of the culture; the plunger was then given a rapid push so that the medium was forced back into the vial. Repetition of this procedure two more times was sufficient to break up most of the clumps. After that, 0.1 ml of the culture was taken as a sample for plating. Each time, the alternate vial in a pair was used for sampling. Two to three dilutions were used for plating (in agreement with preliminary studies) to have a range of 50 to 500 CFU per plate. Four to six plates were used for each sample; each plate was inoculated with a volume of 0.5 ml. The 7H11 agar plates were incubated at 37°C in the presence of 5% CO2 for 3 weeks; the colonies were then counted.
Susceptibility of ceforanide on 7H11 agar plates. Six concentrations of ceforanide were incorporated in 7H11 agar medium. Two inocula of each culture were used so that there was sufficient growth on the control medium. The MIC in these experiments was defined as the lowest concentration that could produce 99 to 100% inhibition when compared with colony counts on the control medium without ceforanide. Moxalactam  30  3  0  0  0  Cefoxitin  15  15  3  0  0  Cefamandole  22  6  3  2  0  Cephalothin  15  7  7  2  2  Cefotaxime  0  3  6  10  14  Cephapirin  0  0  0  9  24  Ceftizoxime  0  0  0  4  29  Ceforanide  0  0  1  0  32 Degradation assay. To determine the dynamics of degradation of ceforanide in 7H12 broth cultures, sample vials were removed from incubation at different times: 0, 24, 72, 120, and 192 h. The cultures were filtered through 0.22-p,m Millipore filters (Millipore Corp., Bedford, Mass.). The vials without M. tuberculosis, containing the same initial concentrations of ceforanide, were also exposed to 37°C and were tested simultaneously with the cultures. The concentration of ceforanide in the filtrate was determined by bioassay, in which a filter paper disk-agar diffusion method with Bacillus subtilis ATCC 6633 as a target organism was used (4, 8) . Fig. 1 , in which the percentage of GI inhibition is plotted against ceforanide concentration. The cultures with MIC = 50.0 ,ug/ml produced the most gentle slope and the cultures with MIC = 6.2 ,ug/ml gave the steepest slope. The distribution of cultures by the R-MIC in the radiometric method and by the MIC in the proportion method have shown good correlation between these two methods ( Table   2 ). The R-MICs and MICs for most of the isolates were in a range between 6.2 and 25 p.g/ml.
RESULTS
No significant differences in susceptibility to ceforanide was found between the cultures susceptible and resistant to the standard tuberculosis drugs. The decrease in both GI and CFU was discovered in the subseml; (B) cultures with MIC = 50.0 ,ug/ml. quent period of cultivation (Fig. 3B) , whereas the events in the control vials (Fig. 3A) reflected the usual dynamics of GI To study the degradation in the presence of and CFU described above. The decrease in GI after addition ,is, four cultures with R-MIC = 50 ,ug/ml were of ceforanide remained irreversible, reaching the negative half-life in those conditions depended on the level (<10). At the same time, the decline in CFU occurred tration of ceforanide. The half-life was the within ca. 1 week after the addition of ceforanide, followed xperiments conducted in the absence of M.
by a slight increase within the next period. The number of in which the initial concentration (50 ,ug/ml) CFU on day 11 of cultivation was reduced by more than for complete growth inhibition. When the log1o compared with the number of CFU in the same vial at tration of ceforanide was lower (25 and 12.5 the moment when ceforanide was added (day 7). These data e growth of M. tuberculosis was inhibited only
show that ceforanide had a bactericidal effect. The increase partially (15 and 50%, respectively), the half-life of ceforanide was shorter (Table 3) .
Correlation between GI and CFU dynamics. The typical dynamics of G0, when M. tuberculosis is cultivated in 7H12 medium, are shown in Fig. 2A . There was an increase up to the maximum, followed by a decrease. Good correlation between GI and CFU dynamics occurred within the first 10 days of cultivation, until the GI reached the maximum. Within the following period of cultivation, when the GI was declining, the number of CFU continued to rise until it stabilized at 1 x 106 to 2 x 106, which is perhaps the maximum under these conditions. Such a relationship suggests that the observed limit of growth probably was due to the limited amount of nutrient substances in this medium. The decline of the GI while the number of CFU was still increasing could be explained as the result of early consumption of the radiolabeled carbon source occurring before the culture conditions became unfavorable for further multiplication of bacteria. The same course of events took place in the presence of low concentrations of ceforanide, which did not inhibit the growth (Fig. 2B) . In the presence of the in the number of CFU after a short period of decline was probably due to deterioration of ceforanide (see above) and was a result of multiplication of the part of the bacterial population that was inhibited but not killed after the single addition of ceforanide.
DISCUSSION
Antibacterial activity of ceforanide against M. tuberculosis clinical isolates was confirmed by three methods: (i) the dynamics of radiometric readings (GI) in 7H12 broth; (ii) the number of CFU in the same medium; and (iii) the proportion method on 7H11 agar plates. Good correlation among these methods suggests that the radiometric method (BACTEC system) is a reliable tool for such studies. Certain limitations should be taken into account. In the vials without drugs, the dynamics of the GI reflect the dynamics of CFU in 7H12 broth only within the period before the GI readings have reached the maximum. This occurs also in vials with drugs if there is a complete inhibition of GI, which in this case reflects inhibition of growth. At the same time, the decline in GI readings after the maximum was reached in control vials without antibacterial agents does not reflect a decline in the number of CFU (which can continue at the attained level or even increase), but more likely is a reflection of depletion of -. the radiolabeled nutrient substrate. The decrease in the GI as a result of addition of the antibacterial agent to the culture is a reflection of complete inhibition of growth but does not necessarily reflect the decline in the number of CFU. Therefore the radiometric method may be considered a reliable tool for determining the MIC but not the MBC. With full appreciation of these limitations, the radiometric method is nevertheless a rapid, reliable, and convenient method for preliminary screening of many antibacterial agents and for subsequent MIC titrations of those selected in screening. This method is not labor intensive, is relatively inexpensive, gives immediate results, requires a short cultivation period, and therefore can be used not only in research but also for studies seeking a nonstandard antituberculosis drug in treatment.
In this study, the activity of ceforanide against 65 clinical isolates of M. tuberculosis corresponds to that found in a previous study in which ceforanide was tested against 12 strains by the broth dilution method (9) . The authors found that the MICs were equal to the MBCs, an indication of bactericidal effect. We have confirmed in this study that ceforanide has a clear bactericidal effect when a concentration determined to be the MIC is used in 7H12 broth.
Most of the tested cultures had an MIC in a range between 6.2 and 25.0 ,ug/ml. Based on the criteria proposed by the National Committee for Clinical Laboratory Standards (1983 tentative standard), more than 60% of the M. tuberculosis strains tested in this study by radiometric or agar plate method would be considered susceptible (MIC < 8.0) or moderately susceptible (MIC < 16.0). However, since these criteria were not derived with mycobacteria, the significance of these breakpoints for mycobacterial infections remains to be determined. Whether the observed efficacy of ceforanide in these in vitro assays can be translated into in vivo therapeutic benefit for infections with M. tuberculosis remains to be determined. Obviously, such drugs should never be used in routine cases of M. tuberculosis infection. However, owing to the increasing incidence of infections with highly drug-resistant organisms (in some cases, resistant to all known standard antituberculosis medications), new approaches to antimicrobial chemotherapy will be required. Development of screening procedures such as those described in this report will facilitate the search for new, potentially useful antimicrobial agents for further testing in animal models and, eventually, in human clinical studies.
